General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines

International Journal of Pediatric Otorhinolaryngology

Volumn 86, Issue , 2016, Pages 224-232

  Leach, Amanda J ^a   Wigger, Christine ^a   Beissbarth, Jemima ^a   Woltring, Donna ^a   Andrews, Ross ^a   Chatfield, Mark D ^a   Smith Vaughan, Heidi ^a   Morris, Peter S ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Middle ear microbiology; Nasopharyngeal carriage; Non typeable Haemophilus influenzae; Otitis media; Pneumococcal conjugate vaccines; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; BACTERIAL PROTEIN; CARRIER PROTEIN; GLPQ PROTEIN, HAEMOPHILUS INFLUENZAE; IMMUNOGLOBULIN D; LIPOPROTEIN; VACCINE;

ACUTE OTITIS MEDIA; ARTICLE; AUSTRALIAN ABORIGINE; BACTERIUM CARRIER; CHILD; COUGHING; EARDRUM PERFORATION; FAMILY SIZE; FEMALE; HEALTH STATUS; HUMAN; IMPETIGO; INFANT; MALE; MATERNAL SMOKING; NONTYPEABLE HAEMOPHILUS INFLUENZAE; NORTHERN TERRITORY; OTITIS MEDIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RHINORRHEA; SCABIES; SECRETORY OTITIS MEDIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SUPPURATIVE OTITIS MEDIA; ACUTE DISEASE; AUSTRALIA; ETHNOLOGY; HETEROZYGOTE; MICROBIOLOGY; MIDDLE EAR; NASOPHARYNX; OCEANIC ANCESTRY GROUP; RISK FACTOR;

ACUTE DISEASE; AUSTRALIA; BACTERIAL PROTEINS; CARRIER PROTEINS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; EAR, MIDDLE; FEMALE; HUMANS; IMMUNOGLOBULIN D; INFANT; LIPOPROTEINS; MALE; NASOPHARYNX; OCEANIC ANCESTRY GROUP; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; PREVALENCE; RISK FACTORS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84969211418     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2016.05.011     Document Type: Article

References (29)

1. Morris P.S., Leach A.J., Silberberg P., Mellon G., Wilson C., Hamilton E., et al. Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey. BMC Pediatr 2005, 5:27-37.
2. Leach A.J., Wigger C., Andrews R., Chatfield M., Smith-Vaughan H., Morris P.S. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules. BMC Pediatr 2014, 14(1):200.
3. Leach A.J., Morris P.S. The burden and outcome of respiratory tract infection in Australian and aboriginal children. Pediatr. Infect. Dis. J. 2007, 26(10 Suppl.):S4-S7.
4. Morris P.S., Leach A.J., Halpin S., Mellon G., Gadil G., Wigger C., et al. An overview of acute otitis media in Australian Aboriginal children living in remote communities. Vaccine 2007, 25(13):2389-2393.
5. Smith-Vaughan H.C., Binks M.J., Marsh R.L., Kaestli M., Ward L., Hare K.M., et al. Dominance of Haemophilus influenzae in ear discharge from Indigenous Australian children with acute otitis media with tympanic membrane perforation. BMC Ear Nose Throat Disord 2013, 13(1):12.
6. Leach A.J., Wigger C., Hare K., Hampton V., Beissbarth J., Andrews R., et al. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. BMC Pediatr 2015, 15(1):162.
7. Roca A., Hill P.C., Townend J., Egere U., Antonio M., Bojang A., et al. Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med 2011, 8(10):e1001107.
8. Leach A.J., Morris P.S., McCallum G.B., Wilson C.A., Stubbs L., Beissbarth J., et al. Emerging pneumococcal carriage serotypes in a high-risk population receiving 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001. BMC Infect. Dis 2009, 9(1):121.
9. Williams S.R., Mernagh P.J., Lee M.H., Tan J.T. Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine. Med. J. Aust 2011, 194(3):116-120.
10. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006, 367(9512):740-748.
11. Schuerman L., Borys D., Hoet B., Forsgren A., Prymula R. Prevention of otitis media: now a reality?. Vaccine 2009, 27(42):5748-5754.
12. GlaxoSmithKline Australia Pty Ltd Product information for AusPAR Synflorix Pneumococcal polysaccharide conjugate vaccine, 10-valent adsorbed GlaxoSmithKline Pty Ltd PM-2010-02793-3-2 accessed 22.10.16. http://www.tga.gov.au/pdf/auspar/auspar-pneumococcal-polysaccharide-vaccine-121022-pi.pdf.
13. Morris P., Leach A., Shah P., Nelson S., Anand A., Daby J., et al. Recommendations for clinical care guidelines on the management of otitis media in Aboriginal & Torres Strait Islander populations 2010.
14. Leach A., Wood Y., Gadil E., Stubbs E., Morris P. Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial. Pediatr. Infect. Dis. J. 2008, 27(8):692-698.
15. Satzke C., Turner P., Virolainen-Julkunen A., Adrian P.V., Antonio M., Hare K.M., et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 2013, 32(1):165-179.
16. Beissbarth J., Binks M., Scarff K., Marsh R., Nosworthy E., Chang A., et al. Non-typeable Haemophilus influenzae and H. haemolyticus identification in the Northern Territory of Australia 2014, Australian Otitis Media Meeting (OMOZ), Melbourne.
17. Bell S.M. The CDS disc method of antibiotic sensitivity testing (calibrated dichotomous sensitivity test). Pathology 1975, 7(4 Suppl.). Suppl-48.
18. Stubbs E., Hare K., Wilson C., Morris P., Leach A.J. Streptococcus pneumoniae and noncapsular Haemophilus influenzae nasal carriage and hand contamination in children: a comparison of two populations at risk of otitis media. Pediatr. Infect. Dis. J. 2005, 24(5):423-428.
19. StataCorp Stata Statistical Software: Release 12 2011, StataCorp LP, College Station, TX.
20. Australian Government Department of Health Care for kids ears 2013.
21. van den Bergh M.R., Spijkerman J., Swinnen K.M., Francois N.A., Pascal T.G., Borys D., et al. Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin. Infect. Dis 2013, 56(3):e30-e39.
22. Palmu A.A., Jokinen J., Borys D., Nieminen H., Ruokokoski E., Siira L., et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet 2013, 381(9862):214-222.
23. Tregnaghi M.W., Saez-Llorens X., Lopez P., Abate H., Smith E., Posleman A., et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial. PLoS Med 2014, 11(6):e1001657.
24. Hammitt L.L., Akech D.O., Morpeth S.C., Karani A., Kihuha N., Nyongesa S., et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health 2014, 2(7):e397-e405.
25. Ben-Shimol S., Givon-Lavi N., Leibovitz E., Raiz S., Greenberg D., Dagan R. Near elimination of otitis media caused by the PCV13 serotypes in Southern Israel shortly after sequential introduction of PCV7/PCV13. Clin. Infect. Dis 2014, 59(12):1724-1732.
26. De Wals P., Lefebvre B., Defay F., Deceuninck G., Boulianne N. Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada. Vaccine 2012, 30(45):6416-6420.
27. Dunne E.M., Smith-Vaughan H.C., Robins-Browne R.M., Mulholland E.K., Satzke C. Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine 2013, 31(19):2333-2342.
28. Pizzutto S.J., Yerkovich S.T., Upham J.W., Hales B.J., Thomas W.R., Chang A.B. Improving immunity to Haemophilus influenzae in children with chronic suppurative lung disease. Vaccine 2015, 33(2):321-326.
29. Murphy T.F. Vaccines for nontypeable Haemophilus influenzae: the future is now. Clin. Vaccine Immunol 2015, 22(5):459-466.